Research article · 15 Apr 2026
Conference abstractPublished 29 Sep 2016
A model of improved acute antibody mediated rejection in murine renal transplantation
Third Affiliated Hospital of Sun Yat-sen University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
6-8 weeks old male C3H and Balb/c mice were used as skin or kidney graft donors and recipients. Donor specific antibody (DSA) levels of recepient serum were monitored within 100 days post skin presensitization. Recipient animals were divided into three groups: The ever reported method group (ST-7dTx) and improved method groups (ST-4dTx, ST-3dTx). Recipient animals were presensitized by transplanting skin grafts before seven, four and three days of kidney transplantation in ST- 7dTx, ST-4dTx and ST-3dTx groups. Animal survival time was recorded. The diagnosis of renal antibody mediated rejection (AMR) was evaluated based on Banff 2013 criteria. DSA-IgG level continously elevated within 50 days after presensitized by skin transplantation and kept a plateau within 50-100 days. DSA-IgM level did not incease remarkably within 100 days post skin presensitization. The median survival time of ST-7dTx, ST-4dTx, and ST-3dTx groups were four, seven and nine days. All recepient animals in ST-7dTx and ST-4dTx groups died within 14 days post kidney transplantation. 17% recepients in ST-3dTx acquired long-term survival (>60d). The dominant death reason for all animals was acute AMR of renal grafts, which met Banff 2013 criteria. Recepient animals in improved models survived and allowed longer time for intervening AMR. So, the improved model is superior to the ever reported one. Some recepient animals in ST-3dTx group can survive, which may interfer the observation results when applying the model to evaluating the effects of therapeutic strategies for renal graft AMR, so ST-4d Tx is a more idea murine acute AMR kidney transplantation model.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Zhao Da-qiang”
- BylineArticles whose byline prints “Li Si-wen”
- BylineArticles whose byline prints “Liao Tao”
- BylineArticles whose byline prints “Huang Zheng-yu”
- BylineArticles whose byline prints “Han Fei”
- BylineArticles whose byline prints “Hua Xue-feng”
- BylineArticles whose byline prints “Li Heng”
- BylineArticles whose byline prints “Sun Qi-quan”
